KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Inventory: 2010-2023

Historic Inventory for Nektar Therapeutics (NKTR) over the last 14 years, with Dec 2023 value amounting to $16.1 million.

  • Nektar Therapeutics' Inventory fell 30.08% to $14.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $14.5 million, marking a year-over-year decrease of 30.08%. This contributed to the annual value of $16.1 million for FY2023, which is 16.15% down from last year.
  • Per Nektar Therapeutics' latest filing, its Inventory stood at $16.1 million for FY2023, which was down 16.15% from $19.2 million recorded in FY2022.
  • Nektar Therapeutics' Inventory's 5-year high stood at $19.2 million during FY2022, with a 5-year trough of $12.7 million in FY2019.
  • Over the past 3 years, Nektar Therapeutics' median Inventory value was $16.1 million (recorded in 2023), while the average stood at $17.0 million.
  • Its Inventory has fluctuated over the past 5 years, first climbed by 21.52% in 2022, then dropped by 16.15% in 2023.
  • Over the past 5 years, Nektar Therapeutics' Inventory (Yearly) stood at $12.7 million in 2019, then climbed by 20.74% to $15.3 million in 2020, then climbed by 3.33% to $15.8 million in 2021, then climbed by 21.52% to $19.2 million in 2022, then declined by 16.15% to $16.1 million in 2023.